Avgi Mamalaki is Research Director HPI, Head of Molecular Biology & Immunobiotechnology Laboratory. She received the Biology degree ("Babes-Bolyai" University, Cluj-Napoca, Romania, 1980), and the D.E.R.B.H. (Diploma des Etudes et de Recherche en Biologie Humaine) and Doctorat d'Etat en Biologie Humaine (Medical School of the University Paris XII "Val-de-Marne", France). She was a post-doctoral researcher in the IMBB, FORTH, Heraclion Crete. She was a visiting researcher in the National Cancer Institute (NCI-FCRDC), Frederick, Maryland, USA, in the laboratory of Human Retroviruses. Since 1990 she has been in HPI. In the recent years, her research interests focuses on exploring the molecular mechanisms involved in hepcidin regulation and the development of immunodiagnostic and immunotherapeutic agents (with emphasis on recombinant human antibodies). She has received and coordinated a large number of funding. She has 3 international patents.

Dr. Alexios Dimitriadis is a post-doctorate research associate at the Hellenic Pasteur Institute. He holds a bachelors’ degree in Biology from the National and Kapodistrian University of Athens, and a doctorate in Medicine from the same university. He has contributed in projects funded by the European Union and the National Strategic Reference Framework, in regards to the study of possible immunotherapeutic methods against Her2/neu positive cancer and the investigation of the pathogenetic role of hepcidin in iron-related diseases. Additionally, he received a scholarship from the State Scholarships Foundation for his study of new biomarkers in Hepatocellular carcinoma. He has published articles in science journals and conference proceedings and has taken part in presentations, seminars and workshops.